- Report
- March 2023
- 147 Pages
Global
From €4368EUR$4,949USD£3,771GBP
- Report
- March 2023
- 147 Pages
Global
From €4368EUR$4,949USD£3,771GBP
- Report
- March 2023
- 147 Pages
Global
From €4368EUR$4,949USD£3,771GBP
- Report
- March 2023
- 147 Pages
Global
From €4368EUR$4,949USD£3,771GBP
- Report
- March 2023
- 147 Pages
Global
From €4368EUR$4,949USD£3,771GBP
- Report
- March 2023
- 147 Pages
Global
From €4368EUR$4,949USD£3,771GBP
- Report
- March 2023
- 147 Pages
Global
From €4368EUR$4,949USD£3,771GBP
- Report
- March 2023
- 147 Pages
Global
From €4368EUR$4,949USD£3,771GBP
- Report
- March 2023
- 147 Pages
Global
From €4368EUR$4,949USD£3,771GBP
- Report
- March 2023
- 147 Pages
Global
From €4368EUR$4,949USD£3,771GBP
- Report
- March 2023
- 147 Pages
Global
From €4368EUR$4,949USD£3,771GBP
- Report
- March 2023
- 147 Pages
Global
From €4368EUR$4,949USD£3,771GBP
- Report
- March 2023
- 162 Pages
Global
From €3177EUR$3,599USD£2,742GBP
- Report
- April 2025
- 143 Pages
Global
From €3530EUR$3,999USD£3,047GBP
- Report
- March 2026
- 136 Pages
France
From €3530EUR$3,999USD£3,047GBP
- Report
- February 2026
- 149 Pages
Canada
From €3530EUR$3,999USD£3,047GBP
- Report
- February 2026
- 141 Pages
India
From €3530EUR$3,999USD£3,047GBP
- Report
- February 2026
- 137 Pages
Australia
From €3530EUR$3,999USD£3,047GBP
- Report
- June 2025
- 119 Pages
Thailand
From €3530EUR$3,999USD£3,047GBP
- Report
- June 2025
- 120 Pages
India
From €3088EUR$3,499USD£2,666GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more